Researchers have been studying Hurricane Harvey's effect on public health and the emergency response by healthcare providers during a major disaster. On Thursday, Aug. 22, they will share what they have learned at a symposium.
The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is looking for malignant pleural mesothelioma patients to try a new treatment that combines immunotherapy with a new drug that accelerates cell death.
A cancer immunotherapy research group at Baylor College of Medicine has secured Investigational New Drug regulatory clearance through the FDA to perform phase I clinical studies in newly-diagnosed adult patients with glioblastoma.
Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
In a new study, ethics scholar Dr. Stephanie Morain explores a trend of oncology trial recruitment via mobile apps, and what these app companies and consumers need to consider in terms of privacy and data protection